{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:03:40Z","timestamp":1791511420928,"version":"4.3.4"},"reference-count":106,"publisher":"SAGE Publications","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2017,8,29]]},"DOI":"10.3233\/jad-170186","type":"journal-article","created":{"date-parts":[[2017,8,18]],"date-time":"2017-08-18T11:09:18Z","timestamp":1503054558000},"page":"183-200","source":"Crossref","is-referenced-by-count":37,"title":["Cerebrospinal Fluid Amyloid-\u03b2 42, Total Tau and Phosphorylated Tau are Low in Patients with Normal Pressure Hydrocephalus: Analogies and Differences with Alzheimer\u2019s Disease"],"prefix":"10.1177","volume":"60","author":[{"given":"Roberto","family":"Santangelo","sequence":"first","affiliation":[{"name":"Department of Neurology, INSPE, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giordano","family":"Cecchetti","sequence":"additional","affiliation":[{"name":"Department of Neurology, INSPE, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Bernasconi","sequence":"additional","affiliation":[{"name":"Department of Neurology, INSPE, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalinda","family":"Cardamone","sequence":"additional","affiliation":[{"name":"Department of Neurology, INSPE, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Barbieri","sequence":"additional","affiliation":[{"name":"Department of Neurology, INSPE, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Pinto","sequence":"additional","affiliation":[{"name":"Department of Neurology, Papa Giovanni XXIII Hospital, Bergamo, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Passerini","sequence":"additional","affiliation":[{"name":"Laboraf, IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Scomazzoni","sequence":"additional","affiliation":[{"name":"Department of Neuroradiology, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Comi","sequence":"additional","affiliation":[{"name":"Department of Neurology, INSPE, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Magnani","sequence":"additional","affiliation":[{"name":"Department of Neurology, INSPE, Vita-Salute University and IRCCS-San Raffaele Hospital, Milan, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-170186_ref1","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/BF01410626","article-title":"The relation of intracranial pressure B-waves to different sleep stages in patients with suspected normal pressure hydrocephalus","volume":"136","author":"Krauss","year":"1995","journal-title":"Acta Neurochir (Wien)"},{"key":"10.3233\/JAD-170186_ref2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.3171\/jns.1997.87.5.0687","article-title":"Dutch normal-pressure hydrocephalus study: Prediction of outcome after shunting by resistance to outflow of cerebrospinal fluid","volume":"87","author":"Boon","year":"1997","journal-title":"J Neurosurg"},{"key":"10.3233\/JAD-170186_ref3","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3171\/jns.1999.90.2.0221","article-title":"Dutch Normal-Pressure Hydrocephalus Study: The role of cerebrovascular disease","volume":"90","author":"Boon","year":"1999","journal-title":"J Neurosurg"},{"key":"10.3233\/JAD-170186_ref4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.mehy.2006.01.029","article-title":"Theoretical considerations on the pathophysiology of normal pressure hydrocephalus (NPH) and NPH-related dementia","volume":"67","author":"Hamlat","year":"2006","journal-title":"Med Hypotheses"},{"key":"10.3233\/JAD-170186_ref5","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ana.22100","article-title":"Amyloid and tau proteins in cortical brain biopsy and Alzheimer\u2019s disease","volume":"68","author":"Leinonen","year":"2010","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170186_ref6","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/jnnp.68.6.778","article-title":"Alzheimer\u2019s disease comorbidity in normal pressure hydrocephalus: Prevalence and shunt response","volume":"68","author":"Golomb","year":"2000","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-170186_ref7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s11910-008-0058-2","article-title":"Normal pressure hydrocephalus: Diagnosis and treatment","volume":"8","author":"Shprecher","year":"2008","journal-title":"Curr Neurol Neurosci Rep"},{"key":"10.3233\/JAD-170186_ref8","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0197-4580(92)90027-U","article-title":"Identification of normal andpathological aging in prospectively studied nondementedelderly humans","volume":"13","author":"Dickson","year":"1992","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170186_ref9","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/archneur.55.9.1185","article-title":"Regional distribution of neuritic plaques in the nondemented elderly and subjects with very mild Alzheimer disease","volume":"55","author":"Haroutunian","year":"1998","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170186_ref10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1002\/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X","article-title":"Tangles and plaques in nondemented aging and \u201cpreclinical\u201d Alzheimer\u2019s disease","volume":"45","author":"Price","year":"1999","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170186_ref11","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00002093-199910000-00009","article-title":"Progression of regional neuropathology in Alzheimer diseaseand normal elderly: Findings from the Nun study","volume":"13","author":"Wolf","year":"1999","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"10.3233\/JAD-170186_ref12","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S1474-4422(03)00487-3","article-title":"Alzheimer\u2019s disease, normal-pressure hydrocephalus, and senescent changes in CSF circulatory physiology: A hypothesis","volume":"2","author":"Silverberg","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170186_ref13","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/jmri.20684","article-title":"Idiopathic normal pressure hydrocephalus may be a \u201ctwo hit\u201d disease: Benign external hydrocephalus in infancy followed by deep white matter ischemia in late adulthood","volume":"24","author":"Bradley","year":"2006","journal-title":"J Magn Reson Imaging"},{"key":"10.3233\/JAD-170186_ref14","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1749-6632.2000.tb06356.x","article-title":"Cerebral amyloid angiopathy: Accumulation of A beta in interstitial fluid drainage pathways in Alzheimer\u2019s disease","volume":"903","author":"Weller","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.3233\/JAD-170186_ref15","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1126\/science.1240514","article-title":"Neuroscience. Garbage truck of the brain","volume":"340","author":"Nedergaard","year":"2013","journal-title":"Science"},{"key":"10.3233\/JAD-170186_ref16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.it.2015.08.006","article-title":"Revisiting the mechanisms of CNS immune privilege","volume":"36","author":"Louveau","year":"2015","journal-title":"Trends Immunol"},{"key":"10.3233\/JAD-170186_ref17","doi-asserted-by":"crossref","unstructured":"Iliff JJ , Wang M , Liao Y , Plogg BA , Peng W , Gundersen GA , Benveniste H , Vates GE , Deane R , Goldman SA , Nagelhus EA , Nedergaard M (2012) A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid \u03b2. Sci Transl Med 4, 147ra111.","DOI":"10.1126\/scitranslmed.3003748"},{"key":"10.3233\/JAD-170186_ref18","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1001\/archneur.1967.00470260086010","article-title":"Brain extracellular space and the sink action of cerebrospinal fluid. Measurement of rabbit brain extracellular space using sucrose labeled with carbon 14","volume":"17","author":"Oldendorf","year":"1967","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170186_ref19","first-page":"431","article-title":"Rapid solute transport throughout the brain via paravascular fluid pathways","volume":"52","author":"Rennels","year":"1990","journal-title":"Adv Neurol"},{"key":"10.3233\/JAD-170186_ref20","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.brainres.2009.12.065","article-title":"Amyloid and tau accumulate in the brains of aged hydrocephalic rats","volume":"1317","author":"Silverberg","year":"2010","journal-title":"Brain Res"},{"key":"10.3233\/JAD-170186_ref21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer\u2019s disease: The amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.3233\/JAD-170186_ref22","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrneurol.2009.219","article-title":"Can Alzheimer disease be prevented by amyloid-beta immunotherapy?","volume":"6","author":"Lemere","year":"2010","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-170186_ref23","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1474-4422(09)70299-6","article-title":"Hypothetical model of dynamic biomarkers of the Alzheimer\u2019s pathological cascade","volume":"9","author":"Jack","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170186_ref24","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical andbiomarker changes in dominantly inherited Alzheimer\u2019s disease","volume":"367","author":"Bateman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-170186_ref25","doi-asserted-by":"crossref","first-page":"253","DOI":"10.3233\/JAD-142451","article-title":"Alzheimer\u2019s DiseaseNeuroimaging Initiative, Cognition, brain atrophy, andcerebrospinal fluid biomarkers changes from preclinical todementia stage of Alzheimer\u2019s disease and the influence ofapolipoprotein E","volume":"45","author":"Susanto","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170186_ref26","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1212\/WNL.0000000000001375","article-title":"Brain structure and function as mediators of the effects of amyloid on memory","volume":"84","author":"Mattsson","year":"2015","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref27","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.tics.2013.08.007","article-title":"Understanding cognitive deficits in Alzheimer\u2019s disease based on neuroimaging findings","volume":"17","author":"Braskie","year":"2013","journal-title":"Trends Cogn Sci"},{"key":"10.3233\/JAD-170186_ref28","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1159\/000334295","article-title":"Relationship between memoryperformance and \u03b2-amyloid deposition at different stagesof Alzheimer\u2019s disease","volume":"10","author":"Ch\u00e9telat","year":"2012","journal-title":"Neurodegener Dis"},{"key":"10.3233\/JAD-170186_ref29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/1471-2377-14-66","article-title":"Evaluation of coexistence of Alzheimer\u2019s disease in idiopathic normal pressure hydrocephalus using ELISA analyses for CSF biomarkers","volume":"14","author":"Lim","year":"2014","journal-title":"BMC Neurol"},{"key":"10.3233\/JAD-170186_ref30","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jns.2015.07.001","article-title":"Cerebrospinal fluid biomarkers forprognosis of long-term cognitive treatment outcomes in patientswith idiopathic normal pressure hydrocephalus","volume":"357","author":"Nakajima","year":"2015","journal-title":"J Neurol Sci"},{"key":"10.3233\/JAD-170186_ref31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.clineuro.2014.01.006","article-title":"Profile of cognitive dysfunction and relation with gait disturbance in normal pressure hydrocephalus","volume":"118","author":"Bugalho","year":"2014","journal-title":"Clin Neurol Neurosurg"},{"key":"10.3233\/JAD-170186_ref32","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/2045-8118-9-7","article-title":"Phosphorylated tau\/amyloid beta 1-42 ratio in ventricularcerebrospinal fluid reflects outcome in idiopathic normal pressurehydrocephalus","volume":"9","author":"Patel","year":"2012","journal-title":"Fluids Barriers CNS"},{"key":"10.3233\/JAD-170186_ref33","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170186_ref34","doi-asserted-by":"crossref","first-page":"333","DOI":"10.31887\/DCNS.2004.6.3\/imckeith","article-title":"Dementia with Lewy bodies","volume":"6","author":"McKeith","year":"2004","journal-title":"Dialogues Clin Neurosci"},{"key":"10.3233\/JAD-170186_ref35","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of reviseddiagnostic criteria for the behavioural variant offrontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"key":"10.3233\/JAD-170186_ref36","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref37","first-page":"601","article-title":"Visual evoked potentials in the white New Zealand rabbit: Source localization and normative aspects","volume":"67","author":"Romani","year":"1991","journal-title":"Boll Soc Ital Biol Sper"},{"key":"10.3233\/JAD-170186_ref38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1212\/WNL.47.1.1","article-title":"Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP international workshop","volume":"47","author":"Litvan","year":"1996","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref39","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1212\/WNL.0b013e31827f0fd1","article-title":"Criteria for the diagnosis of corticobasal degeneration","volume":"80","author":"Armstrong","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref40","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1227\/01.NEU.0000168185.29659.C5","article-title":"Diagnosing idiopathic normal-pressure hydrocephalus","volume":"57","author":"Relkin","year":"2005","journal-title":"Neurosurgery"},{"key":"10.3233\/JAD-170186_ref41","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1532-5415.1986.tb05480.x","article-title":"Performance-oriented assessment of mobility problems in elderly patients","volume":"34","author":"Tinetti","year":"1986","journal-title":"J Am Geriatr Soc"},{"key":"10.3233\/JAD-170186_ref42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fnagi.2013.00006","article-title":"Cerebrospinal fluid biomarkers for differentiation of frontotemporal lobar degeneration from Alzheimer\u2019s disease","volume":"5","author":"Irwin","year":"2013","journal-title":"Front Aging Neurosci"},{"key":"10.3233\/JAD-170186_ref43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00401-009-0612-2","article-title":"Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: An update","volume":"119","author":"Mackenzie","year":"2010","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-170186_ref44","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1365-2796.2004.01380.x","article-title":"Mild cognitive impairment\u2013beyond controversies, towards a consensus: Report of the International Working Group on Mild Cognitive Impairment","volume":"256","author":"Winblad","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-170186_ref45","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2796.2004.01388.x","article-title":"Mild cognitive impairment as a diagnostic entity","volume":"256","author":"Petersen","year":"2004","journal-title":"J Intern Med"},{"key":"10.3233\/JAD-170186_ref46","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3233\/JAD-160360","article-title":"Combining cerebrospinal fluid biomarkers and neuropsychological assessment: A simple and cost-effective algorithm to predict the progression from mild cognitive impairment to Alzheimer\u2019s disease dementia","volume":"54","author":"Mazzeo","year":"2016","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170186_ref47","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1161\/01.STR.32.6.1318","article-title":"A new rating scale for age-related white matter changes applicable to MRI and CT","volume":"32","author":"Wahlund","year":"2001","journal-title":"Stroke"},{"key":"10.3233\/JAD-170186_ref48","first-page":"1776","article-title":"Tau and Abeta42 in cerebrospinal fluid from healthy adults21-93 years of age: Establishment of reference values","volume":"47","author":"Sj\u00f6gren","year":"2001","journal-title":"ClinChem"},{"key":"10.3233\/JAD-170186_ref49","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/archneurol.2008.596","article-title":"Cerebrospinal fluid beta-amyloid 42 and tau proteins asbiomarkers of Alzheimer-type pathologic changes in the brain","volume":"66","author":"Tapiola","year":"2009","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170186_ref50","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S1474-4422(06)70355-6","article-title":"Association between CSF biomarkers and incipient Alzheimer\u2019s disease in patients with mild cognitive impairment: A follow-up study","volume":"5","author":"Hansson","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170186_ref51","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s10072-014-1644-5","article-title":"Further evidence about the crucial role of CSF biomarkers in diagnosis of posterior cortical atrophy","volume":"35","author":"Coppi","year":"2014","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-170186_ref52","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.3233\/JAD-141122","article-title":"Cerebrospinal fluid biomarkers can play a pivotal role in the diagnostic work up of primary progressive aphasia","volume":"43","author":"Santangelo","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170186_ref53","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/S1474-4422(14)70090-0","article-title":"Advancing research diagnostic criteria for Alzheimer\u2019s disease:The IWG-2 criteria","volume":"13","author":"Dubois","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170186_ref54","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1001\/jama.1963.03060120024016","article-title":"Studies of illness in the aged. The index of ADL: A standardized measure of biological and psychosocial function","volume":"185","author":"Katz","year":"1963","journal-title":"JAMA"},{"key":"10.3233\/JAD-170186_ref55","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/geront\/9.3_Part_1.179","article-title":"Assessment of older people: Self-maintaining and instrumental activities of daily living","volume":"9","author":"Lawton","year":"1969","journal-title":"Gerontologist"},{"key":"10.3233\/JAD-170186_ref56","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\u201cMini-mental state\u201d.A practical method for grading the cognitive state of patients forthe clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-170186_ref57","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1468-1331.1996.tb00423.x","article-title":"Mini-Mental State Examination: A normative study in Italianelderly population","volume":"3","author":"Magni","year":"1996","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-170186_ref58","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1192\/bjp.140.6.566","article-title":"A new clinical scale for the staging of dementia","volume":"140","author":"Hughes","year":"1982","journal-title":"Br J Psychiatry"},{"key":"10.3233\/JAD-170186_ref59","first-page":"278","article-title":"Tre test clinici di memoria verbale a lungo termine. Taratura su soggetti normali","volume":"2","author":"Novelli","year":"1986","journal-title":"Arch Psicol Neurol Psichiatr"},{"key":"10.3233\/JAD-170186_ref60","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s10072-012-1130-x","article-title":"Forward and backward span for verbal and visuo-spatial data: Standardization and normative data from an Italian adult population","volume":"34","author":"Monaco","year":"2013","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-170186_ref61","volume-title":"Standardizzazione e taratura italiana di test neuropsicologici: Gruppo italiano per lo studio neuropsicologico dell\u2019invecchiamento","author":"Spinnler","year":"1987"},{"key":"10.3233\/JAD-170186_ref62","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2190\/5A0F-936P-VG8N-0F5R","article-title":"The ten point clock test: A quick screen and grading method for cognitive impairment in medical and surgical patients","volume":"24","author":"Manos","year":"1994","journal-title":"Int J Psychiatry Med"},{"key":"10.3233\/JAD-170186_ref63","first-page":"189","article-title":"Raven\u2019s coloured progressive matrices: Normative values on 305 adult normal controls","volume":"2","author":"Basso","year":"1987","journal-title":"Funct Neurol"},{"key":"10.3233\/JAD-170186_ref64","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1212\/WNL.0b013e31828c2fda","article-title":"Idiopathic normal-pressure hydrocephalus: Pathophysiology and diagnosis by CSF biomarkers","volume":"80","author":"Jeppsson","year":"2013","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref65","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jpsychires.2010.07.011","article-title":"Biochemical studies in Normal Pressure Hydrocephalus (NPH) patients: Change in CSF levels of amyloid precursor protein (APP), amyloid-beta (A\u03b2) peptide and phospho-tau","volume":"45","author":"Ray","year":"2011","journal-title":"J Psychiatr Res"},{"key":"10.3233\/JAD-170186_ref66","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jalz.2011.01.003","article-title":"Cognitive, biochemical, and imaging profile of patients suffering from idiopathic normal pressure hydrocephalus","volume":"7","author":"Tarnaris","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170186_ref67","unstructured":"Tsai A , Malek-Ahmadi M , Kahlon V , Sabbagh MN (2014) Differences in cerebrospinal fluid biomarkers between clinically diagnosed idiopathic normal pressure hydrocephalus and Alzheimer\u2019s Disease. J Alzheimers Dis Park 4, pii: 1000150."},{"key":"10.3233\/JAD-170186_ref68","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1468-1331.2006.01593.x","article-title":"Cerebrospinal fluid tau, phospho-tau181 and beta-amyloid1-42 in idiopathic normal pressure hydrocephalus: A discrimination from Alzheimer\u2019s disease","volume":"14","author":"Kapaki","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-170186_ref69","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1600-0404.2007.00890.x","article-title":"CSF biomarkers in the evaluation of idiopathic normal pressure hydrocephalus","volume":"116","author":"Agren-Wilsson","year":"2007","journal-title":"Acta Neurol Scand"},{"key":"10.3233\/JAD-170186_ref70","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3233\/JAD-142622","article-title":"Idiopathic normal pressure hydrocephalus has a different cerebrospinal fluid biomarker profile from Alzheimer\u2019s disease","volume":"45","author":"Jingami","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170186_ref71","doi-asserted-by":"crossref","first-page":"e0119973","DOI":"10.1371\/journal.pone.0119973","article-title":"Impact ofcerebrospinal fluid shunting for idiopathic normal pressurehydrocephalus on the amyloid cascade","volume":"10","author":"Moriya","year":"2015","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170186_ref72","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.1468-1331.2012.03781.x","article-title":"Soluble amyloid precursor protein \u03b1 in the cerebrospinal fluid as a diagnostic and prognostic biomarker for idiopathic normal pressure hydrocephalus","volume":"20","author":"Miyajima","year":"2013","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-170186_ref73","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1111\/j.1468-1331.2006.01553.x","article-title":"Ventricular cerebrospinal fluidneurofilament protein levels decrease in parallel with whitematter pathology after shunt surgery in normal pressurehydrocephalus","volume":"14","author":"Tullberg","year":"2007","journal-title":"Eur J Neurol"},{"key":"10.3233\/JAD-170186_ref74","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1212\/01.WNL.0000046581.81650.D0","article-title":"CSF Abeta 42 levels correlate with amyloid-neuropathology in a population-based autopsy study","volume":"60","author":"Strozyk","year":"2003","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref75","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1523\/JNEUROSCI.21-02-00372.2001","article-title":"Age-dependent changes in brain, CSF, and plasma amyloid (beta) protein in the Tg2576 transgenic mouse model of Alzheimer\u2019s disease","volume":"21","author":"Kawarabayashi","year":"2001","journal-title":"J Neurosci"},{"key":"10.3233\/JAD-170186_ref76","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0304-3940(00)01697-9","article-title":"Transient increase in total tau but not phospho-tau in human cerebrospinal fluid after acute stroke","volume":"297","author":"Hesse","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.3233\/JAD-170186_ref77","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1136\/jnnp.71.3.401","article-title":"Highly increased CSF tau protein and decreased beta-amyloid (1-42) in sporadic CJD: A discrimination from Alzheimer\u2019s disease?","volume":"71","author":"Kapaki","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-170186_ref78","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s004010100423","article-title":"Specific tau phosphorylation sites correlate with severity of neuronal cytopathology in Alzheimer\u2019s disease","volume":"103","author":"Augustinack","year":"2002","journal-title":"Acta Neuropathol (Berl)"},{"key":"10.3233\/JAD-170186_ref79","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1212\/WNL.0000000000000916","article-title":"Alzheimer CSF biomarkers may be misleading in normal-pressure hydrocephalus","volume":"83","author":"Graff-Radford","year":"2014","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref80","doi-asserted-by":"crossref","first-page":"e91974","DOI":"10.1371\/journal.pone.0091974","article-title":"Cerebrospinal fluid biomarker and brain biopsyfindings in idiopathic normal pressure hydrocephalus","volume":"9","author":"Pyykk\u00f6","year":"2014","journal-title":"PLoS One"},{"key":"10.3233\/JAD-170186_ref81","doi-asserted-by":"crossref","first-page":"20709","DOI":"10.1038\/srep20709","article-title":"Cerebral white matter lesions - associations with A\u03b2 isoforms and amyloid PET","volume":"6","author":"van Westen","year":"2016","journal-title":"Sci Rep"},{"key":"10.3233\/JAD-170186_ref82","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/bpa.12182","article-title":"Regional multiple pathology scores are associated withcognitive decline in Lewy body dementias","volume":"25","author":"Howlett","year":"2015","journal-title":"Brain Pathol"},{"key":"10.3233\/JAD-170186_ref83","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1212\/01.WNL.0000165987.89198.65","article-title":"Cognitive differences in dementia patients with autopsy-verified AD, Lewy body pathology, or both","volume":"64","author":"Kraybill","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref84","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1212\/01.wnl.0000249130.63615.cc","article-title":"Differences in neuropathologic characteristics across the Lewy body dementia spectrum","volume":"67","author":"Ballard","year":"2006","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref85","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1001\/jama.2015.4669","article-title":"Prevalence of amyloid PETpositivity in dementia syndromes: A meta-analysis","volume":"313","author":"Ossenkoppele","year":"2015","journal-title":"JAMA"},{"key":"10.3233\/JAD-170186_ref86","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jagp.2013.03.001","article-title":"Amyloid PET imaging in Lewy body disorders","volume":"23","author":"Donaghy","year":"2015","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.3233\/JAD-170186_ref87","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/NEN.0000000000000191","article-title":"Correlations between mini-mental state examination score, cerebrospinal fluid biomarkers, and pathology observed in brain biopsies of patients with normal-pressure hydrocephalus","volume":"74","author":"Elobeid","year":"2015","journal-title":"J Neuropathol Exp Neurol"},{"key":"10.3233\/JAD-170186_ref88","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jalz.2007.08.006","article-title":"Core candidate neurochemical and imagingbiomarkers of Alzheimer\u2019s disease","volume":"4","author":"Hampel","year":"2008","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-170186_ref89","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.exger.2009.10.010","article-title":"Total and phosphorylated tau protein as biological markers of Alzheimer\u2019s disease","volume":"45","author":"Hampel","year":"2010","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-170186_ref90","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/gerona\/61.7.755","article-title":"Cerebrospinal fluid amyloid beta42\/phosphorylated tau ratio discriminates between Alzheimer\u2019s disease and vascular dementia","volume":"61","author":"de Jong","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.3233\/JAD-170186_ref91","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1212\/01.WNL.0000156914.16988.56","article-title":"CSF Abeta42 and tau or phosphorylated tau and prediction of progressive mild cognitive impairment","volume":"64","author":"Herukka","year":"2005","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref92","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.3233\/JAD-2010-100207","article-title":"Evaluation of CSF biomarkers as predictors of Alzheimer\u2019s disease: A clinical follow-up study of 4.7 years","volume":"21","author":"Hertze","year":"2010","journal-title":"J Alzheimers Dis"},{"key":"10.3233\/JAD-170186_ref93","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1227\/01.neu.0000306100.83882.81","article-title":"The neuropsychology of patients with clinically diagnosed idiopathic normal pressure hydrocephalus","volume":"61","author":"Hellstr\u00f6m","year":"2007","journal-title":"Neurosurgery"},{"key":"10.3233\/JAD-170186_ref94","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000085858","article-title":"Association between cognitive impairment and gait disturbance in patients with idiopathic normal pressure hydrocephalus","volume":"20","author":"Miyoshi","year":"2005","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.3233\/JAD-170186_ref95","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1136\/jnnp.67.6.723","article-title":"Specific patterns of cognitive impairment in patients with idiopathic normal pressure hydrocephalus and Alzheimer\u2019s disease: A pilot study","volume":"67","author":"Iddon","year":"1999","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.3233\/JAD-170186_ref96","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1111\/j.1471-4159.2006.03989.x","article-title":"Molecular mechanisms for Alzheimer\u2019s disease: Implications for neuroimaging and therapeutics","volume":"97","author":"Masters","year":"2006","journal-title":"J Neurochem"},{"key":"10.3233\/JAD-170186_ref97","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archneurol.2011.1538","article-title":"Mechanism of amyloid removal in patients with Alzheimer disease treated with gantenerumab","volume":"69","author":"Ostrowitzki","year":"2012","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-170186_ref98","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S1474-4422(10)70043-0","article-title":"11C-PiB PET assessment of change in fibrillar amyloid-beta load in patients with Alzheimer\u2019s disease treated with bapineuzumab: A phase 2, double-blind, placebo-controlled, ascending-dose study","volume":"9","author":"Rinne","year":"2010","journal-title":"Lancet Neurol"},{"key":"10.3233\/JAD-170186_ref99","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","article-title":"Twophase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019sdisease","volume":"370","author":"Salloway","year":"2014","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-170186_ref100","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1312889","article-title":"Phase 3 trials of solanezumab for mild-to-moderate Alzheimer\u2019s disease","volume":"370","author":"Doody","year":"2014","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-170186_ref101","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13195-016-0189-7","article-title":"Bapineuzumab 3000 and 3001 Clinical Study Investigators, Bapineuzumab for mild to moderate Alzheimer\u2019s disease in two global, randomized, phase 3 trials","volume":"8","author":"Vandenberghe","year":"2016","journal-title":"Alzheimers Res Ther"},{"key":"10.3233\/JAD-170186_ref102","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0197-4580(00)00173-1","article-title":"Quantitative neurohistological features of frontotemporal degeneration","volume":"21","author":"Arnold","year":"2000","journal-title":"Neurobiol Aging"},{"key":"10.3233\/JAD-170186_ref103","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1212\/WNL.58.11.1622","article-title":"Tau and Abeta42 protein in CSF of patients with frontotemporal degeneration","volume":"58","author":"Riemenschneider","year":"2002","journal-title":"Neurology"},{"key":"10.3233\/JAD-170186_ref104","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1002\/ana.21451","article-title":"A\u03b2 amyloid and glucose metabolism in three variants of primary progressive aphasia","volume":"64","author":"Rabinovici","year":"2008","journal-title":"Ann Neurol"},{"key":"10.3233\/JAD-170186_ref105","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1038\/nn.4017","article-title":"The case for rejecting the amyloid cascade hypothesis","volume":"18","author":"Herrup","year":"2015","journal-title":"Nat Neurosci"},{"key":"10.3233\/JAD-170186_ref106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.3171\/2011.2.JNS101316","article-title":"Use of cerebrospinal fluid amyloid-\u03b2 and total tau protein to predict favorable surgical outcomes in patients with idiopathic normal pressure hydrocephalus","volume":"115","author":"Tarnaris","year":"2011","journal-title":"J Neurosurg"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-170186","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:04:42Z","timestamp":1777370682000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-170186"}},"subtitle":[],"editor":[{"given":"Willemijn","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,29]]},"references-count":106,"journal-issue":{"issue":"1"},"URL":"https:\/\/doi.org\/10.3233\/jad-170186","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,29]]}}}